Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
Frontiers in Immunology
|
December 26, 2022
Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer
Hui Peng, Lijin Li, Chong Zuo, et al.
Oncoimmunology
|
September 20, 2018
Recruitment of CCR2<sup>+</sup> tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer
Julie G Grossman, Timothy M Nywening, Brian A Belt, et al.
Surgery
|
June 19, 2024
Overexpression of human DNA polymerase theta is a biomarker of aggressive and DNA repair-deficient papillary thyroid cancers
C Corbin Frye, Lena Tennant, Ashley Yeager, et al.
Annals of Surgical Oncology
|
October 25, 2024
ASO Visual Abstract: Plasma Ceramide C24:0/C16:0 Ratio is Associated with Improved Survival in Patients with Pancreatic Ductal Adenocarcinoma
Joshua D Mitchell, Usman Panni, Nicole Fergestrom, et al.
Annals of Surgical Oncology
|
September 21, 2024
Plasma Ceramide C24:0/C16:0 Ratio is Associated with Improved Survival in Patients with Pancreatic Ductal Adenocarcinoma
Joshua D Mitchell, Usman Panni, Nicole Fergestrom, et al.
Cancer Immunology, Immunotherapy : CII
|
March 22, 2014
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer
Roheena Z Panni, Dominic E Sanford, Brian A Belt, et al.
Cancer Research Communications
|
May 25, 2022
<i>In silico</i> epitope prediction analyses highlight the potential for distracting antigen immunodominance with allogeneic cancer vaccines
C Alston James, Peter Ronning, Darren Cullinan, et al.
Cancer Gene Therapy
|
December 16, 2017
Development of an adenovirus vector vaccine platform for targeting dendritic cells
Piyush K Sharma, Igor P Dmitriev, Elena A Kashentseva, et al.
Oncotarget
|
August 16, 2019
Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles
Matthew S Strand, Bradley A Krasnick, Hua Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2021
Neoadjuvant FOLFIRINOX Therapy Is Associated with Increased Effector T Cells and Reduced Suppressor Cells in Patients with Pancreatic Cancer
Hui Peng, C Alston James, Darren R Cullinan, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
Frontiers in Immunology
|
December 26, 2022
Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer
Hui Peng, Lijin Li, Chong Zuo, et al.
Oncoimmunology
|
September 20, 2018
Recruitment of CCR2<sup>+</sup> tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer
Julie G Grossman, Timothy M Nywening, Brian A Belt, et al.
Surgery
|
June 19, 2024
Overexpression of human DNA polymerase theta is a biomarker of aggressive and DNA repair-deficient papillary thyroid cancers
C Corbin Frye, Lena Tennant, Ashley Yeager, et al.
Annals of Surgical Oncology
|
October 25, 2024
ASO Visual Abstract: Plasma Ceramide C24:0/C16:0 Ratio is Associated with Improved Survival in Patients with Pancreatic Ductal Adenocarcinoma
Joshua D Mitchell, Usman Panni, Nicole Fergestrom, et al.
Annals of Surgical Oncology
|
September 21, 2024
Plasma Ceramide C24:0/C16:0 Ratio is Associated with Improved Survival in Patients with Pancreatic Ductal Adenocarcinoma
Joshua D Mitchell, Usman Panni, Nicole Fergestrom, et al.
Cancer Immunology, Immunotherapy : CII
|
March 22, 2014
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer
Roheena Z Panni, Dominic E Sanford, Brian A Belt, et al.
Cancer Research Communications
|
May 25, 2022
<i>In silico</i> epitope prediction analyses highlight the potential for distracting antigen immunodominance with allogeneic cancer vaccines
C Alston James, Peter Ronning, Darren Cullinan, et al.
Cancer Gene Therapy
|
December 16, 2017
Development of an adenovirus vector vaccine platform for targeting dendritic cells
Piyush K Sharma, Igor P Dmitriev, Elena A Kashentseva, et al.
Oncotarget
|
August 16, 2019
Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles
Matthew S Strand, Bradley A Krasnick, Hua Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2021
Neoadjuvant FOLFIRINOX Therapy Is Associated with Increased Effector T Cells and Reduced Suppressor Cells in Patients with Pancreatic Cancer
Hui Peng, C Alston James, Darren R Cullinan, et al.
Page
of 6